STOCK TITAN
  1. Home
  2. Sec-filings
  3. TELA
  4. [Form 4] TELA Bio, Inc. Insider Trading Activity

[Form 4] TELA Bio, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

TELA Bio, Inc. director and CEO Antony Koblish reported a mix of equity awards and tax-related share dispositions. On February 20, 2026, he was granted 176,000 shares of common stock as restricted stock units that will vest in four equal annual installments beginning on February 20, 2027, subject to his continued service. He also received a stock option for 261,000 shares, vesting 25% on February 20, 2027 and the remaining 75% in equal monthly installments over the following 36 months, also subject to continued service. On February 21, 23, and 24, 2026, a total of 28,?? shares of common stock were disposed of at prices between $0.7174 and $0.7852 per share to cover withholding taxes upon RSU vesting, with shares withheld by the issuer rather than sold in open-market transactions.

Positive

  • None.

Negative

  • None.
Insider KOBLISH ANTONY
Role Chief Executive Officer
Type Security Shares Price Value
Exercise Price or Tax Liability Common Stock 3,900 $0.7852 $3K
Exercise Price or Tax Liability Common Stock 11,631 $0.766 $9K
Exercise Price or Tax Liability Common Stock 12,494 $0.7174 $9K
Grant/Award Stock Option (Right to Buy) 261,000 $0.00 $0.00
Grant/Award Common Stock 176,000 $0.00 $0.00
Holdings After Transaction: Stock Option (Right to Buy) — 261,000 shares (Direct); Common Stock — 586,210 shares (Direct)
Footnotes (3)
  1. F1. These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 20, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates.
  2. F2. Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
  3. F3. The option vests 25% on February 20, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KOBLISH ANTONY
(Last) (First) (Middle)
C/O TELA BIO, INC.
1 GREAT VALLEY PARKWAY, SUITE 24
(Street)
MALVERN PA 19355
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TELA Bio, Inc. [ TELA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/20/2026 A 176,000(1) A $0 766,110 D
Common Stock 02/21/2026 F 12,494(2) D $0.7174 753,616 D
Common Stock 02/23/2026 F 11,631(2) D $0.766 741,985 D
Common Stock 02/24/2026 F 3,900(2) D $0.7852 586,210 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $0.717 02/20/2026 A 261,000 (3) 02/20/2036 Common Stock 261,000 $0 261,000 D
Explanation of Responses:
1. These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 20, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates.
2. Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
3. The option vests 25% on February 20, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.
/s/ Megan Smeykal, Attorney-in-Fact 02/24/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR